Animal Health Leaps Forward with Human Tech

Animal health is undergoing a significant transformation, mirroring advancements in human medicine. Technologies such as mRNA, monoclonal antibodies, wearable devices, and AI-driven drug discovery are rapidly enhancing veterinary care and welfare for both pets and livestock.

Despite these revolutionary benefits, the investment in animal health constitutes a mere 0.6 percent of global health spending. This disparity threatens to impede progress in a field integral to human well-being, as approximately 75 percent of human infectious diseases originate in animals.

The recent return of the New World screwworm to the United States highlights the urgency. Scientists are employing gene-editing techniques and novel pour-on treatments to combat this parasitic threat, alongside numerous USDA-funded research projects.

RNA technology, including self-amplifying RNA particle technology, is crucial for developing vaccines against swine, canine, and feline influenza. Similarly, mRNA technology is accelerating vaccine development for livestock diseases like foot-and-mouth disease in cattle and avian influenza.

Monoclonal antibody therapies, previously used for human conditions, are now treating canine cancers and inflammatory conditions. Wearable monitoring tools, akin to human fitness trackers, are enabling early disease detection in cattle, leading to proactive interventions.

These advancements foster a more proactive approach to animal care, yielding better outcomes for animals and humans alike. Furthermore, breakthroughs in veterinary science, such as ivermectin, have historically led to significant human medical treatments, underscoring the interconnectedness of animal and human health.